Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 4:19 PM View:  | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 07-Oct-24 | Option Sale | 715 | $60.12 | $42,985.80 | (7%) 10.22K to 9.51K | |
| 08-Oct-24 4:19 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 04-Oct-24 | Option Exercise | 1,453 | -- | -- | 17% 8.77K to 10.22K | |
| 10-Sep-24 4:15 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 09-Sep-24 | Option Sale | 551 | $73.57 | $40,538.80 | (3%) 18.7K to 18.15K | |
| 10-Sep-24 4:15 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 06-Sep-24 | Option Exercise | 1,139 | -- | -- | 6% 17.57K to 18.7K | |
| 04-Sep-24 4:26 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 03-Sep-24 | Option Sale | 318 | $76.99 | $24,482.50 | (< 1%) 1.6M to 1.6M | |
| 04-Sep-24 5:42 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 03-Sep-24 | Option Sale | 114 | $76.99 | $8,776.75 | (< 1%) 17.68K to 17.57K | |
| 04-Sep-24 4:26 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 30-Aug-24 | Option Exercise | 652 | -- | -- | < 1% 1.6M to 1.6M | |
| 04-Sep-24 5:42 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 30-Aug-24 | Option Exercise | 233 | -- | -- | 1% 17.45K to 17.68K | |
| 30-Aug-24 4:34 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 29-Aug-24 | Option Sale | 162 | $78.03 | $12,640.20 | (< 1%) 17.61K to 17.45K | |
| 30-Aug-24 4:37 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 29-Aug-24 | Option Sale | 162 | $78.03 | $12,640.20 | (2%) 8.93K to 8.77K | |
| 30-Aug-24 4:32 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 29-Aug-24 | Option Sale | 300 | $78.03 | $23,407.80 | (< 1%) 1.6M to 1.6M | |
| 30-Aug-24 4:32 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 28-Aug-24 | Option Exercise | 611 | -- | -- | < 1% 1.6M to 1.6M | |
| 30-Aug-24 4:34 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 28-Aug-24 | Option Exercise | 329 | -- | -- | 2% 17.28K to 17.61K | |
| 29-Aug-24 10:00 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 28-Aug-24 | Option Sale | 1,319 | $79.39 | $104,722.00 | (7%) 18.6K to 17.28K | |
| 29-Aug-24 4:45 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 28-Aug-24 | Option Sale | 1,321 | $79.39 | $104,881.00 | (13%) 9.92K to 8.6K | |
| 30-Aug-24 4:37 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 28-Aug-24 | Option Exercise | 329 | -- | -- | 4% 8.6K to 8.93K | |
| 29-Aug-24 4:45 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 27-Aug-24 | Option Exercise | 2,652 | -- | -- | 36% 7.27K to 9.92K | |
| 29-Aug-24 10:00 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 27-Aug-24 | Option Exercise | 2,652 | -- | -- | 17% 15.95K to 18.6K | |
| 13-Aug-24 4:33 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 12-Aug-24 | Option Sale | 254 | $84.10 | $21,362.60 | (< 1%) 1.6M to 1.6M | |
| 13-Aug-24 4:33 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 09-Aug-24 | Option Exercise | 522 | -- | -- | < 1% 1.6M to 1.6M | |
| 02-Aug-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 31-Jul-24 | Sale (Planned) | 15,000 | $119.96 | $1,799,440.00 | (< 1%) 6.87M to 6.86M | |
| 26-Jul-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 24-Jul-24 | Sale (Planned) | 15,000 | $117.80 | $1,766,970.00 | (< 1%) 6.89M to 6.87M | |
| 19-Jul-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 17-Jul-24 | Sale (Planned) | 15,000 | $122.84 | $1,842,650.00 | (< 1%) 6.9M to 6.89M | |
| 16-Jul-24 4:08 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 15-Jul-24 | Sale (Planned) | 15,000 | $121.12 | $1,816,800.00 | (< 1%) 1.61M to 1.6M | |
| 12-Jul-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 10-Jul-24 | Sale (Planned) | 15,000 | $117.08 | $1,756,180.00 | (< 1%) 6.92M to 6.9M | |
| 09-Jul-24 4:34 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 08-Jul-24 | Option Sale | 689 | $118.24 | $81,465.40 | (9%) 7.96K to 7.27K | |
| 09-Jul-24 4:34 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 05-Jul-24 | Option Exercise | 1,452 | -- | -- | 22% 6.51K to 7.96K | |
| 28-Jun-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 26-Jun-24 | Sale (Planned) | 15,000 | $127.22 | $1,908,290.00 | (< 1%) 6.93M to 6.92M | |
| 21-Jun-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 18-Jun-24 | Sale (Planned) | 15,000 | $133.57 | $2,003,560.00 | (< 1%) 6.95M to 6.93M | |
| 18-Jun-24 4:05 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 17-Jun-24 | Sale (Planned) | 15,000 | $138.16 | $2,072,400.00 | (< 1%) 1.63M to 1.61M | |
| 17-Jun-24 4:12 PM View: | Bancel Stephane Chief Executive Officer Director | Moderna, Inc. (MRNA) | 14-Jun-24 | Acquisition (other) | 26,840 | -- | -- | < 1% 21.08M to 21.1M | |
| 14-Jun-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 12-Jun-24 | Sale (Planned) | 15,000 | $147.21 | $2,208,070.00 | (< 1%) 6.96M to 6.95M | |
| 11-Jun-24 7:01 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 11-Jun-24 | Sale | 202,832 | $148.34 | $30,087,300.00 | (2%) 11.61M to 11.41M | |
| 11-Jun-24 4:05 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 10-Jun-24 | Option Sale | 5,178 | $148.09 | $766,785.00 | (25%) 21.13K to 15.95K | |
| 11-Jun-24 4:05 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 07-Jun-24 | Option Exercise | 10,247 | -- | -- | 94% 10.88K to 21.13K | |
| 07-Jun-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 05-Jun-24 | Sale (Planned) | 15,000 | $151.25 | $2,268,800.00 | (< 1%) 11.63M to 11.61M | |
| 04-Jun-24 5:12 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 03-Jun-24 | Option Sale | 122 | $140.72 | $17,167.80 | (1%) 11.0K to 10.88K | |
| 04-Jun-24 5:27 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 03-Jun-24 | Option Sale | 691 | $140.72 | $97,237.40 | (10%) 7.2K to 6.51K | |
| 04-Jun-24 5:20 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 03-Jun-24 | Option Sale | 339 | $140.72 | $47,704.00 | (< 1%) 1.63M to 1.63M | |
| 04-Jun-24 5:27 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 31-May-24 | Option Exercise | 1,326 | -- | -- | 23% 5.87K to 7.2K | |
| 04-Jun-24 5:20 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 31-May-24 | Option Exercise | 651 | -- | -- | < 1% 1.63M to 1.63M | |
| 04-Jun-24 5:12 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 31-May-24 | Option Exercise | 232 | -- | -- | 2% 10.77K to 11.0K | |
| 30-May-24 4:36 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 29-May-24 | Option Sale | 183 | $144.51 | $26,444.40 | (3%) 6.05K to 5.87K | |
| 30-May-24 4:14 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 29-May-24 | Option Sale | 341 | $144.51 | $49,276.10 | (< 1%) 1.63M to 1.63M | |
| 31-May-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 29-May-24 | Sale (Planned) | 20,000 | $145.08 | $2,901,580.00 | (< 1%) 11.65M to 11.63M | |
| 30-May-24 4:27 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 29-May-24 | Option Sale | 183 | $144.51 | $26,444.40 | (2%) 10.95K to 10.77K | |
| 30-May-24 4:27 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 28-May-24 | Option Exercise | 328 | -- | -- | 3% 10.62K to 10.95K | |
| 29-May-24 4:12 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 28-May-24 | Option Sale | 1,296 | $162.47 | $210,566.00 | (11%) 11.92K to 10.62K | |
| 30-May-24 4:36 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 28-May-24 | Option Exercise | 328 | -- | -- | 6% 5.73K to 6.05K | |
| 29-May-24 4:16 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 28-May-24 | Option Sale | 648 | $162.47 | $105,283.00 | (10%) 6.37K to 5.73K |
